$NVEC

NVE (NVEC) Earnings Put Valuation Back In Focus As DCF Tells A Different Story

Simply Wall St reports NVE (NVEC) first-quarter results: revenue of $11.03 million, net income of $6.39 million, and EPS of $1.32 from continuing operations. The stock closed at $117.55, with a 31.6x P/E. The article cites a DCF fair value estimate of $35.32 per share.

Original reporting
Published Jul 26, 2026, 6:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 26, 2026, 6:29 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NVE (NVEC) Earnings Put Valuation Back In Focus As DCF Tells A Different Story — source image
Decision brief

The 30-second read

$NVECNeutralLow
01

Why it matters

The actionable takeaway is a valuation discrepancy: the article argues P/E (31.6x) looks reasonable versus peers, while its DCF implies the current price ($117.55) may be too high.

02

Market read

Traders may use the earnings datapoints and the stated DCF gap to reassess valuation-driven positioning, but there is no new guidance or event beyond the reported quarter.

03

What to watch

The article flags segment concentration and market-cap size risk, but does not quantify backlog, guidance, or balance-sheet drivers that could reconcile P/E and DCF.

Relevance 4/10Novelty 4/10Timing: post-earnings valuation framing after the latest quarter results

Background

Simply Wall St summarizes NVEC’s latest quarter results and then contrasts a P/E-based valuation view with its own DCF model.

Company-level read

Ticker impact

$NVECNeutralMedium confidence
Context

Article cites NVEC Q1 revenue of $11.03M, net income $6.39M, EPS $1.32, and discusses valuation vs a DCF fair value.

Expected impact

Near-term trading likely remains volatile, with valuation-sensitive positioning around the earnings-driven move.

Evidence & confidence

The text provides specific earnings datapoints and a DCF vs market price gap, but it does not add new guidance or a fresh catalyst beyond the reported quarter.

Market effects

Semiconductor investors may continue to weigh small-cap component names on valuation multiples versus cash-flow models.

No specific regional market mechanism beyond US small-cap semiconductor sentiment.

Limited, as the article is company-specific and does not cite global supply-demand shocks.

Counterpoint

DCF fair value ($35.32) may be overly conservative if cash flows normalize upward after the earnings-driven momentum, making the P/E lens more relevant for timing.

Key entities

  • NVE (NVEC)

    Semiconductor-related company discussed with Q1 revenue, net income, EPS, and valuation comparisons (P/E vs DCF).

Related articles

$NVECMed

NVE (NVEC) Q1 2027 Earnings Call Transcript

NVE Corp (NVEC) Q1 2027 results showed net income up 79% to $6.39 million, or $1.32 per diluted share, on higher revenue. Operating expenses rose mainly from performance-based compensation, while expense as a % of revenue fell to 15% from 19%. Cash and marketable securities rose to $43.9 million. The company launched two MRI-safe wafer-level chip scale sensors and announced CEO succession.

$NVECMed

NVE CORP /NEW/ (NVEC): Results of Operations and Financial Condition

NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nve_ex99z1.htm PRESS RELEASE Press Release NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend Revenue increases 81% and net income increases 79% EDEN PRAIRIE, Minn.—July 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today financial result

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.